Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.

Area of Science:

• Psychopharmacology
• Neuroscience
• Mental Health Research

Background:

• Microdosing psychedelics involves regular, sub-perceptual doses of substances like LSD or psilocybin.
• Full-dose psychedelic therapies show promise for mental health conditions, but microdosing offers a potentially lower-risk approach.
• Growing cultural interest in microdosing necessitates scientific investigation into its effects.

Purpose of the Study:

• To investigate the relationship between psychedelic microdosing and differences in personality, mental health, and creativity.
• To explore whether individuals who microdose exhibit distinct psychological profiles compared to non-microdosers.

Main Methods:

• An observational study design was employed, recruiting participants from online forums.
• Participants self-reported their microdosing habits and completed validated questionnaires assessing dysfunctional attitudes, wisdom, emotionality, and open-mindedness.
• Creativity was assessed using the Unusual Uses Task.

Main Results:

• Microdosers (current and former) reported significantly lower dysfunctional attitudes and negative emotionality compared to controls.
• Participants who microdosed scored higher on measures of wisdom, open-mindedness, and creativity.
• Statistical analyses indicated significant correlations between microdosing and these positive psychological outcomes.

Conclusions:

• The study provides preliminary evidence suggesting that psychedelic microdosing is associated with enhanced psychological well-being and cognitive function.
• These findings support the need for rigorous, controlled experimental research to confirm the safety and efficacy of microdosing.
• Psychedelic microdosing presents a novel paradigm with potential implications for future therapeutic and research applications.